Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Instill Bio Inc TIL

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:TIL)

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Instil Bio, Inc. (TIL) And Encourages Stockholders to Reach Out

ACCESS Newswire 2 hours ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

ACCESS Newswire 20 hours ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Stockholders to Connect

ACCESS Newswire 1 day ago

Instil Bio, Inc. (TIL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

ACCESS Newswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

ACCESS Newswire 3 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Instil Bio, Inc. (TIL) and Encourages Stockholders to Learn More About the Investigation

ACCESS Newswire 4 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL

ACCESS Newswire 4 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Investors to Inquire about Securities Investigation

ACCESS Newswire 5 days ago

Opinion & Analysis (NDAQ:TIL)

No current opinion is available.

Bullboard Posts (NDAQ:TIL)

Sell buddy sell.Wow.

Otherwise you guys out there will be losing your money with this stock today anyway
coolfooldumbguy - 7 days ago

Instil Bio, Inc. (NASDAQ:TIL): Promising Pipeline and Collab

http://beyondspx.com/2024/08/02/instil-bio-inc-nasdaqtil-promising-pipeline-and-collaboration-agreements-but-significant-challenges-ahead...
MikeTester - August 3, 2024

halted this morning

Anybody else watching this one?  Halted after upticking last week.
mapleleaf - June 21, 2021

November 7th, 2018 Till Receives Initial Cash Payment of US

http://tillcap.com/wp-content/uploads/2018/11/TIL-2018.11.07-NR-18-10-TILL-Receives-Initial-Cash-Payment-from-IG-Coppers-Sale-of-the...
CarrFlournoy - November 7, 2018

What Is a Share Repurchase? With 5 million cash do it

What Is a Share Repurchase? -- The Motley Fool https://www.fool.com/knowledge-center/what-is-a-share-repurchase.aspx ...
CarrFlournoy - November 6, 2018

EMX Royalty Receives $65 Million Cash (news out today)

distribution to Til Capital pending news now  should get paid the same time
CarrFlournoy - October 30, 2018